Gadopiclenol not checked

Guerbet · P03277

FollowEvery change as it happens, and a Monday email
Stage
in the US · approved in the EU
Next date
Phase 3 trial completes
Trials
3 active
13 in total · 4 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Steno-occlusive Disease
Main trialPhase 3
“Compare the diagnostic performance of gadopiclenol against gadoterate meglumine in patients with vascular diseases of supra-aortic, peripheral, or abdominal / renal arteries using MRI”In the company’s words, NCT07348640 on ClinicalTrials.gov
Other names
Elucirem · Elucirem/Vueway · P03277

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials13

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 31 Dec 2027 Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease
Phase 3Completed 11 Sep 2020 Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
Phase 3Completed 9 Dec 2020 Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)
Phase 3Completed 28 Nov 2024 Performance of Elucirem in DSC-MRI Perfusion of Brain Gliomas
Phase 3Completed 6 May 2025 Evaluation of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and Children
Phase 2Completed Jan 2018 P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
Phase 2Completed 18 Dec 2019 Pharmacokinetics, Safety and Efficacy of P03277 in Pediatric Patients Undergoing Central Nervous System Contrast-enhanced MRI
Phase 2Completed 30 Sep 2024 Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of Age
Phase 1/2Completed 17 Apr 2015 Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions
Phase 1Completed 27 Jul 2021 Pharmacokinetics and Safety of Gadopiclenol in Japanese Healthy Volunteers
Phase 4Ended not given Pilot study to explore the diagnostic value of gadopiclenol in pathological and radiological insights with multiparametric MRI enhancement in breast cancer.
Phase 4Authorised not given Phase IV, single-center, randomized, crossover clinical trial to validate the use of gadopiclenol versus gadobutrol in the evaluation of magnetic resonance imaging (MRI) diagnosis of perianal fistula associated with Crohn's disease
Phase 3Authorised not given A Pilot Study on the Use of Gadopiclenol for Enhanced Cardiac MRI in Children with Congenital Heart Conditions: A self-controlled, non-randomised, open-label study to compare the image quality and diagnostic performance of gadopiclenol versus gadoterate meglumine
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Gadopiclenol

Following is part of Solo: you see every change to Gadopiclenol the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in